Cancer Profiling Industry Forecast to Hit $22.97 Billion by 2029 With a Strong 11.2% CAGR

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Cancer Profiling Market?

The cancer profiling market has experienced rapid expansion in recent years. Its value is expected to rise from $13.48 billion in 2024 to $15 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.3%. The historical drivers for this growth include increasing cancer incidence rates, the development of precision medicine approaches, the clinical integration of biomarkers, progress in drug development and targeted therapies, heightened awareness, and patient advocacy efforts.

The cancer profiling market is projected to experience swift expansion over the coming years, with its size anticipated to reach “$22.97 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.2%. Factors contributing to this growth during the forecast period include the integration of artificial intelligence, global collaborations in research, the expanding applications of liquid biopsy, regulatory support for precision medicine, and a heightened focus on early detection. Key trends identified for the forecast period encompass the dominance of liquid biopsy, comprehensive genomic profiling, the emergence of immunoprofiling, collaborative data sharing networks, and single-cell sequencing.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9912&type=smp

What Are The Key Drivers Of Growth In The Cancer Profiling Market?

The rising occurrence of cancer is anticipated to stimulate the expansion of the cancer profiling market moving forward. Cancer incidence refers to the count of newly diagnosed cancer cases within a specific population during a defined period. This increase in cancer cases is attributed to urbanization, an expanding aging demographic, evolving lifestyle habits, as well as environmental and genetic factors. Cancer profiling assists in identifying particular molecular or genetic changes in a tumor, such as gene mutations or other alterations in tumor DNA, which is valuable in the cancer treatment pathway. For example, in 2022, the American Cancer Society, a US-based voluntary organization, estimated that the United States would see approximately 1.9 million new cancer cases diagnosed and 609,360 cancer deaths. Therefore, the escalating incidence of cancer is a primary driver for the growth of the cancer profiling market.

What Are The Major Segment Types Covered In The Cancer Profiling Market?

The cancer profilingmarket covered in this report is segmented –

1) By Technology: Immunoassays; PCR (Polymerized Chain Reaction); NGS (Next-Generation Sequencing); Microarrays; In-Situ Hybridization

2) By Biomarker Type: Genomic Biomarkers; Protein Biomarkers

3) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Melanoma Cancer; Other Cancers

4) By Application: Research Applications; Clinical Applications; Screening; Diagnostics; Prognostics; Other Applications

Subsegments:

1) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting; Luminex xMAP Technology; Radioimmunoassays

2) By PCR (Polymerase Chain Reaction): Quantitative PCR (qPCR); Digital PCR (dPCR); Reverse Transcription PCR (RT-PCR)

3) By NGS (Next-Generation Sequencing): Whole Genome Sequencing (WGS); Whole Exome Sequencing (WES); Targeted Sequencing; RNA Sequencing (RNA-Seq)

4) By Microarrays: DNA Microarrays; RNA Microarrays; SNP Arrays

5) By In-Situ Hybridization: Fluorescence In-Situ Hybridization (FISH); Chromogenic In-Situ Hybridization (CISH)

How Are Trends Influencing The Cancer Profiling Market?

Leading companies within the cancer profiling market are focused on developing innovations like broad coverage. Broad coverage entails the comprehensive analysis of a wide spectrum of genetic mutations, biomarkers, or molecular targets. For example, a test evaluates 517 cancer-relevant genes across nearly 30 solid tumor types. In March 2022, Illumina, Inc., a US-based biotechnology company, introduced the TruSight Oncology Comprehensive (TSO) test, which represented a significant advancement in cancer diagnostics. A new in vitro diagnostic test in Europe profiles cancer mutations to guide patients toward targeted therapies. This test spans 517 genes across nearly 30 solid tumor types, analyzing both DNA and RNA. With a rapid four- to five-day turnaround, it delivers faster results and is CE-marked for European quality standards, reducing the need for multiple gene assays on different tissue samples.

Which Leading Companies Dominate The Cancer Profiling Market Share?

Major companies operating in the cancer profiling market include Illumina Inc., Qiagen NV, NeoGenomics Inc., Sysmex Corporation, HTG Molecular Diagnostics Inc., Caris Life Sciences, NanoString Technologies Inc., Guardant Health Inc., Foundation Medicine Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Genscript Biotech Corporation, Tempus Labs Inc., Hologic Inc., Predictive Oncology Inc., Abbott Laboratories, Agilent Technologies Inc., PerkinElmer Inc., Siemens Healthineers, Genomic Health Inc., Natera Inc., ArcherDX Inc., Personal Genome Diagnostics Inc., Enzo Biochem Inc., Cancer Genetics Inc., OncoDNA SA, Ribomed Biotechnologies Inc., Biocartis Group NV, N-of-One Inc., Cynvenio Biosystems Inc., Inivata Ltd., Burning Rock Biotech Limited, PathAI Inc., GENEWIZ Inc., Genoptix Inc., Oncomine Dx Target Test, OmniSeq Comprehensive, Resolution Bioscience, OncoCyte Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report

Which Geographies Are Emerging As Strong Markets For The Cancer Profiling Industry?

North America was the largest region in the cancer profiling market in 2024. The regions covered in the cancer profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Cancer Profiling Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9912&type=smp

Browse Through More Reports Similar to the Global Cancer Profiling Market 2025, By The Business Research Company

Pain Management Devices And Therapies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Metabolomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Isothermal Nucleic Acid Amplification Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795